12/09/2024 08:11
|
Medical, Health & Aged Care
– Breakthrough Therapy designation for NTX-001 granted by FDA
– Preparation is underway for the Phase 3 program to begin in early 2025
CHESTERBROOK, Pa.--BUSINESS WIRE--
Neuraptive...